QUINAZOLINE AND INDOLE COMPOUNDS TO TREAT MEDICAL DISORDERS
申请人:Achillion Pharmaceuticals, Inc.
公开号:EP3939591A1
公开(公告)日:2022-01-19
Compounds, methods of use, and processes for making inhibitors of Complement Factor B are provided.
本研究提供了用于制造补体因子 B 抑制剂的化合物、使用方法和工艺。
Fe(III)/NaBH<sub>4</sub>-Mediated Free Radical Hydrofluorination of Unactivated Alkenes
作者:Timothy J. Barker、Dale L. Boger
DOI:10.1021/ja3063716
日期:2012.8.22
A powerful Fe(III)/NaBH(4)-mediated freeradical hydrofluorination of unactivated alkenes is disclosed using Selectfluor reagent as a source of fluorine and resulting in exclusive Markovnikov addition. In contrast to the traditional and unmanageable freeradical hydrofluorination of alkenes, the Fe(III)/NaBH(4)-mediated reaction is conducted under exceptionally mild reaction conditions (0 °C, 5 min